Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT03303339 · COMPLETED
Trial details
- NCT number
- NCT03303339
- Sponsor
- Cardiff Oncology
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-17
- Primary completion
- 2021-11-17
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.